ArticleBioinformatics advances2026
Discovering paracrine regulators of cell type composition from spatial transcriptomics using SPER.
Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: A defining characteristic of biological tissue is its cell type composition. Many pathologies and chronic diseases are associated with perturbations from the homeostatic composition, and these transformations can lead to aberrant or deleterious tissue function. Spatial transcriptomics enables the concurrent measurement of gene expression and cell type composition, providing an opportunity to identify transcripts that co-vary with and potentially influence nearby cell composition. However, no method yet exists to systematically identify such intercellular regulatory factors. Results: Here, we develop Spatial Paired Expression Ratio (SPER), a computational approach to evaluate the spatial dependence between transcript abundance and cell type proportions in spatial transcriptomics. We demonstrate the ability of SPER to accurately detect paracrine drivers of cellular abundance using simulated data. Using publicly available spatial transcriptomics data from mouse brain and human lung, we show that genes identified by SPER show statistical enrichment for both extracellular secretion and participation in known receptor-ligand interactions, supporting their potential role as compositional regulators. Taken together, SPER represents a general approach to discover paracrine drivers of cellular compositional changes from spatial transcriptomics. Availability and implementation: The methods are implemented in R and available at: https://github.com/TianxiaoNYU/SPER.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.